Clark Asset Management’s AbbVie ABBV Stock Holding History

Clark Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$940K	Buy	3,737 +237	+7%	+$51K	0.07%	100
2026 Q1	$761K	Buy	3,500 +71	+2%	+$15.7K	0.07%	95
2025 Q4	$784K	Buy	3,429 +54	+2%	+$12.3K	0.08%	89
2025 Q3	$781K	Sell	3,375 -31	-0.9%	-$6.31K	0.09%	85
2025 Q2	$632K	Buy	3,406 +1,667	+96%	+$310K	0.09%	91
2025 Q1	$364K	Buy	+1,739	New	+$338K	0.06%	105

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clark Asset Management's ABBV Position: Q2 2026 in Review

Clark Asset Management increased its AbbVie (ABBV) stake by 6.8% in Q2 2026, buying an estimated $51K and bringing the position to 3,737 shares worth $940K. The position accounts for 0.07% of the portfolio, ranked #100.

Clark Asset Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Clark Asset Management held 3,737 shares of AbbVie worth $940K as of Q2 2026.
Clark Asset Management bought 237 AbbVie shares in Q2 2026, an estimated $51K.
AbbVie made up 0.07% of Clark Asset Management's portfolio in Q2 2026, its #100 holding.
Clark Asset Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clark Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.